COVID-19 & Cancer

Early in 2020, we watched with growing alarm as early warnings of the virulence of SARS-CoV-2 started pouring in from Wuhan, and later, from Lombardy. At The Cancer Letter, we quickly decided to chart a course for intensive coverage of the pandemic as it reached our shores—oncologists are well-poised to take the lead in shaping research on COVID-19, and exposure mitigation strategies for high-risk patients. This coverage is collected here.

COVID-19 & Cancer Free Funding Opportunities

Astellas C3 Prize focuses on challenges of COVID-19 for people with cancer

Navigating a cancer diagnosis is difficult, and even more so during a global pandemic.

September 18, 2020

Vol.46 No.35

By Andy Krivoshik

COVID-19 & Cancer Free

Francis Collins: “We’ve just got to get this done. Because people are dying and time is passing.”

NIH Director Francis S. Collins said he expects at least one of the vaccines against COVID-19 to be proven safe and effective by the end of 2020.

September 18, 2020

Vol.46 No.35

By Alexandria Carolan

Conversation with The Cancer Letter COVID-19 & Cancer Free

John Carpten: Inaugural AACR report calls for legislative action on disparate burden of cancer

The American Association of Cancer Research Sept. 16 published a comprehensive report on disparities in cancer, describing in deep detail the outsized toll that cancer exacts on racial and ethnic minorities and other underserved populations.

September 18, 2020

Vol.46 No.35

By Matthew Bin Han Ong

Conversation with The Cancer Letter COVID-19 & Cancer Free

Barry Sleckman reflects on difficult months in Birmingham

On Jan. 6, Barry P. Sleckman’s started his job as director of the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham.

September 18, 2020

Vol.46 No.35

By Paul Goldberg

COVID-19 & Cancer Free Guest Editorial

HOLA COVID-19 study focuses on disruption of cancer care in Latin America

As of September, more than 270,000 deaths have been confirmed in Latin American countries due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

September 18, 2020

Vol.46 No.35

By Carolina Bernabe, Ana I. Velázquez Mañana, Coral Olazagasti and Narjust Florez

COVID-19 & Cancer Free Guest Editorial

Seeing COVID-19 through a cloud of cigarette smoke

The unprecedented COVID-19 pandemic makes it possible to compare and contrast the public health and political responses to previous health crises.

September 18, 2020

Vol.46 No.35

By Alan Blum and Eric Solberg

COVID-19 & Cancer Free Guest Editorial

COVID-19 threatens to increase cancer mortality

This January, the American Cancer Society reported the sharpest drop in U.S. cancer mortality ever recorded. Between 2016 and 2017, the death rate from cancer fell 2.2%, continuing the trajectory of a 29% decline in cancer mortality since 1991.

September 18, 2020

Vol.46 No.35

By Shelley A. DuBois and Raymond N. DuBois

COVID-19 & Cancer Free Guest Editorial

Delivering a cancer-free frontier during COVID-19

As the only National Cancer Institute-designated Comprehensive Cancer Center in the Mountain West—a region that includes Utah, Idaho, Montana, Nevada, and Wyoming, covering 17% of the landmass of the continental United States—Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has a longstanding focus on improving cancer research, prevention, and treatment strategies for our patients and communities.

September 04, 2020

Vol.46 No.33

By Mary Beckerle

COVID-19 & Cancer Free

The Cancer Letter invites oncology leaders to share insight, strategize on COVID-19

At The Cancer Letter, we watched with growing alarm as early warnings of the virulence of SARS-CoV-2 started pouring in from Wuhan, and later, from Lombardy.

August 06, 2020

Vol.46 No.32